News About: Pharm. Industry
Pharmaceutical makers brace for supermarket’s selling
The majority of OTC markers are considering selling medicines in supermarkets and drugstores if the government allows them to do so.
Outwardly, these pharmaceutical companies are voicing an opposition to supermarke...
Unified OTC distribution attracts leading drug makers
More and more pharmaceutical companies are focusing on unified distribution of their flagship products by associate wholesalers in the midst of stagnant OTC sales.
Market sources say pharmaceutical companies will b...
Pfizer’s Lipitor patent rejected by patent court
The Patent Court of Korea has made its ruling against two patents that Pfizer holds on Lipitor, its top-selling cholesterol drug.
Despite the court’s rejection over Lipitor patents, Pfizer Korea said it will appeal...
Health ministry, Roche make deal over Fuzeon
The Ministry of Health, Welfare and Family Affairs is trying to cut a deal with Roche Korea, a Korean unit of Swiss based multinational firm, over the possible of Fuzeon, a new drug for AIDS, according to pharmaceutic...
Isu Chemical steps up takeover bid
Isu Chemical Group has made it clear that it would expand its attempts to acquire a promising pharmaceutical firm.
The group is also aiming to establish a new hospital-consultation company to strengthen its presenc...
Dong-A Pharm ranks first in 2007 drug output
Dong-A Pharmaceutical placed the first rank in last year‘s pharmaceutical production value with 594.0 billion won, according to data released by the Korea Pharmaceutical Manufacturers Association.
Hanmi Pharm came ...
Three generic makers gain ground on Lipitor
Korea is shaping up to be the biggest shift yet to a generic drug, potentially saving the nation’s medication costs.
Doctors say that for those who take medication to reduce cholesterol, the low-priced alternative...
Bioequivalence issue irks domestic makers
Korean pharmaceutical manufacturers are again concerned about the possible impact of generic drugs’ bioequivalence data fabrication, which has been raised by the National Health Insurance Corporation.
Their reactio...
Korea Exchange OKs Myungmoon’s plan to join main bourseKorea's bourse operator Korea Exchange says that Myungmoon Pharm’s stocks will be listed in the KOSPI from July 10.
With its public listing in main bourse, the company’s fres...
|
Korea’s pharmaceutical output surpasses W13 tril. in 2007
The nation’s production of drugs, etc. amounted to 13.46 trillion won last year, up 9.7 percent from 2006, according to data released by the Korea Pharmaceutical Manufacturers Association.
Data showed that output o...
